Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 2266 to 2280 of 8981 results

  1. Tislelizumab with chemotherapy for untreated advanced oesophageal squamous cell cancer [ID5113]

    In development Reference number: GID-TA11025 Expected publication date:  10 February 2027

    Technology appraisal guidance
    In development

  2. Lenacapavir for preventing HIV-1 in people aged 16 years or older [ID6495]

    In development Reference number: GID-TA11638 Expected publication date: TBC

    Technology appraisal guidance
    In development

  3. Camizestrant with palbociclib for untreated oestrogen receptor-positive HER2-negative metastatic breast cancer after adjuvant endocrine treatment [ID6534]

    Awaiting development Reference number: GID-TA11686 Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  4. Polihexanide 0.8 mg/ml eye drops for treating acanthamoeba keratitis in people 12 years and over [ID6497]

    In development Reference number: GID-TA11643 Expected publication date: TBC

    Technology appraisal guidance
    In development

  5. Inavolisib with palbociclib and fulvestrant for treating recurrent hormone receptor-positive HER2-negative PIK3CA-positive advanced breast cancer after adjuvant endocrine treatment [ID6425]

    In development Reference number: GID-TA11519 Expected publication date: TBC

    Technology appraisal guidance
    In development

  6. Familial Breast Cancer: initial assessment and genetic testing (update)

    In development Reference number: GID-NG10438 Expected publication date:  22 April 2027

    NICE guideline
    In development

  7. Upadacitinib for treating giant cell arteritis [ID6299]

    In development Reference number: GID-TA11330 Expected publication date: TBC

    Technology appraisal guidance
    In development

  8. Polycystic ovary syndrome: assessment and management

    In development Reference number: GID-NG10436 Expected publication date:  09 December 2026

    NICE guideline
    In development

  9. Glycopyrronium bromide cream for treating severe primary axillary hyperhidrosis [ID6487]

    In development Reference number: GID-TA11628 Expected publication date: TBC

    Technology appraisal guidance
    In development

  10. Lymphatico-venous anastomosis for chronic lymphoedema

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  11. High resolution anoscopy and laser therapy for intraepithelial neoplasia of the anus in high risk or immunocompromised patients

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  12. Transarterial Chemoembolisation for inoperable hepatocellular carcinoma

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  13. The Extraperitoneal approach to left sided colorectal resections ( EXPERTS) Procedure

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  14. Use of a glue or sealant to achieve lung volume reduction in emphysema and lung cancer

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  15. Percutaneous cryotherapy (PCT) for the therapy of primary lung cancer or metastatic lung cancer

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation